Beryllium sensitization is characterized by the presence of beryllium- specific CD4+ T cells in the peripheral blood of individuals exposed to beryllium in the workplace. These individuals are asymptomatic and have normal pulmonary function, chest radiographs and lung biopsies. A subset of beryllium-sensitized individuals eventually develops chronic beryllium disease (CBD) at a rate of approximately 10% per year. The factors involved in the localization of beryllium-specific CD4+ T cells to the lung and in the progression from beryllium sensitization to disease remain unknown. It is possible that beryllium sensitization without disease involves the development of peryllium-responsive T cells whereas the evolution to disease involves a particular type of T cell recognition or particular type of T cell function. We now hypothesize that this progression from sensitization to disease is a multifactorial process related to the absolute number of beryllium-responsive T cells in the peripheral blood and changes in the frequency of these beryllium- responsive T cells in the peripheral blood over time can predict this progression to disease. Studies are proposed to verify that beryllium- specific CD4+ T cells are more abundant in the peripheral blood of individuals with CBD as compared to beryllium sensitization. We will also study blood and BAL from CBD patients in order to determine whether the same TCR repertoires exist in beryllium-reactive CD4+ T cells in these different compartments We will also determine whether the pattern of cytokine production by beryllium-reactive CD4+ T cells is different in sensitization versus disease. Separate studies will focus on changes in the frequency of beryllium-reactive CD4+ T cells in the peripheral blood of beryllium-sensitized subjects over time in order to determine whether increases in this frequency are associated with the progression from sensitization to disease. Together, these studies will provide new insights into the immunopathogenesis of beryllium-induced disease.

Agency
National Institute of Health (NIH)
Institute
National Institute of Environmental Health Sciences (NIEHS)
Type
Research Program Projects (P01)
Project #
1P01ES011810-01
Application #
6557112
Study Section
Special Emphasis Panel (ZES1)
Project Start
2002-09-01
Project End
2007-08-31
Budget Start
Budget End
Support Year
1
Fiscal Year
2002
Total Cost
Indirect Cost
Name
National Jewish Health
Department
Type
DUNS #
City
Denver
State
CO
Country
United States
Zip Code
80206
Mroz, Margaret M; Ferguson, John H; Faino, Anna V et al. (2018) Effect of inhaled corticosteroids on lung function in chronic beryllium disease. Respir Med 138S:S14-S19
Li, Li; Silveira, Lori J; Hamzeh, Nabeel et al. (2016) Beryllium-induced lung disease exhibits expression profiles similar to sarcoidosis. Eur Respir J 47:1797-808
Falta, M T; Tinega, A N; Mack, D G et al. (2016) Metal-specific CD4+ T-cell responses induced by beryllium exposure in HLA-DP2 transgenic mice. Mucosal Immunol 9:218-28
Tooker, Brian C; Ozawa, Katherine; Newman, Lee S (2016) CpG promoter methylation status is not a prognostic indicator of gene expression in beryllium challenge. J Immunotoxicol 13:417-27
Fontenot, Andrew P; Falta, Michael T; Kappler, John W et al. (2016) Beryllium-Induced Hypersensitivity: Genetic Susceptibility and Neoantigen Generation. J Immunol 196:22-7
McKee, A S; Mack, D G; Crawford, F et al. (2015) MyD88 dependence of beryllium-induced dendritic cell trafficking and CD4? T-cell priming. Mucosal Immunol 8:1237-47
Tooker, Brian C; Brindley, Stephen M; Chiarappa-Zucca, Marina L et al. (2015) Accelerator mass spectrometry detection of beryllium ions in the antigen processing and presentation pathway. J Immunotoxicol 12:181-7
Li, Li; Hamzeh, Nabeel; Gillespie, May et al. (2015) Beryllium increases the CD14(dim)CD16+ subset in the lung of chronic beryllium disease. PLoS One 10:e0117276
Li, L; Huang, Z; Gillespie, M et al. (2014) p38 Mitogen-Activated Protein Kinase in beryllium-induced dendritic cell activation. Hum Immunol 75:1155-62
Bowerman, Natalie A; Falta, Michael T; Mack, Douglas G et al. (2014) Identification of multiple public TCR repertoires in chronic beryllium disease. J Immunol 192:4571-80

Showing the most recent 10 out of 68 publications